Glucose variability increases with age in type 2 diabetes patients
This study characterized continuous glucose monitoring data in patients with Type 2 diabetes in China, revealing associations between glycemic metrics and various factors.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study characterized continuous glucose monitoring data in patients with Type 2 diabetes in China, revealing associations between glycemic metrics and various factors.
Glunovo probiotic added to metformin in adults with type 2 diabetes.
This study evaluated the use of insulin degludec and insulin aspart guided by a clinical decision support system for glycemic control in hospitalized patients with type 2 diabetes, finding a significant percentage of blood glucose measurements within target range.
This study evaluated an open-source hybrid closed-loop automated insulin delivery system in perioperative patients with Type 2 diabetes, finding it significantly improved glucose control compared to conventional insulin pump therapy.
This study evaluated the effects of semaglutide on glycemic control in adults with Type 1 diabetes using automated insulin delivery. Semaglutide improved the percentage of time spent in the target glucose range significantly.
The study investigated the impact of semaglutide on insulin needs in individuals with type 1 diabetes using pump therapy, revealing significant reductions in insulin requirements.
This study evaluated the impact of sitagliptin on diabetic nephropathy in adolescents with type 1 diabetes, finding significant improvements in several metabolic parameters.
This study evaluated the effectiveness of smart insulin dosage software versus traditional physician experience in managing hyperglycemia in T2DM patients receiving insulin treatment, finding significant advantages for the software.
This study evaluated the impact of switching from self-monitoring of blood glucose (SMBG) to continuous glucose monitoring (CGM) in adults with Type 1 diabetes, finding significant improvements in glycaemic quality.
This study evaluated the efficacy and safety of the Tubeless Omnipod 5 automated insulin delivery system compared to traditional pump therapy with continuous glucose monitoring in adults with Type 1 diabetes.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.